Evidence map›Paper›PMID 36173308›Full record

ArticleMicrobiology spectrum2022

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.

Jian-Hang Huang, Jie Wang, Xiao-Qiang Chai, Zhong-Chen Li, Ying-Hua Jiang, Jun Li, Xing Liu, Jia Fan, Jia-Bin Cai, Feng Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jian-Hang Huang *Minhang Hospital, Fudan Universitygrid.8547.e, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical of Sciences, Fudan University, Shanghai, China.
Jie Wang *Minhang Hospital, Fudan Universitygrid.8547.e, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical of Sciences, Fudan University, Shanghai, China.
Xiao-Qiang Chai *Department of Liver Surgery and Transplantation of Zhongshan Hospitalgrid.413087.9, Liver Cancer Institute of Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan Universitygrid.8547.e, Shanghai, China.
Zhong-Chen LiDepartment of Liver Surgery and Transplantation of Zhongshan Hospitalgrid.413087.9, Liver Cancer Institute of Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan Universitygrid.8547.e, Shanghai, China.
Ying-Hua JiangMinhang Hospital, Fudan Universitygrid.8547.e, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical of Sciences, Fudan University, Shanghai, China.
Jun LiDepartment of General Surgery, Shanghai TongRen Hospital, Shanghai, China.
Xing LiuDepartment of Central Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jia FanDepartment of Liver Surgery and Transplantation of Zhongshan Hospitalgrid.413087.9, Liver Cancer Institute of Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan Universitygrid.8547.e, Shanghai, China.
Jia-Bin CaiDepartment of Liver Surgery and Transplantation of Zhongshan Hospitalgrid.413087.9, Liver Cancer Institute of Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan Universitygrid.8547.e, Shanghai, China.
Feng LiuMinhang Hospital, Fudan Universitygrid.8547.e, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical of Sciences, Fudan University, Shanghai, China.ORCID 0000-0003-1933-9437

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbiota is implicated in hepatocellular carcinoma (HCC). The spectrum of intratumoral microbiota associated with HCC progression remains elusive. Fluorescence

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsBacteriaHumansIn Situ Hybridization, FluorescenceProteobacteriaRNA, Ribosomal, 16STumor MicroenvironmentRNA, Ribosomal, 16Sbacteriafluorescence in situ hybridizationhepatocellular carcinomamachine learningmicrobiota

Identifiers

PMID36173308
PMCPMC9602924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.